Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2

Molecular Cell

Volumn 11, Issue 6, 2003, Pages 1457-1466

  Garami, Attila ^a   Zwartkruis, Fried J T ^b   Nobukuni, Takahiro ^a   Joaquin, Manel ^a   Roccio, Marta ^b   Stocker, Hugo ^c   Kozma, Sara C ^a   Hafen, Ernst ^c   Bos, Johannes L ^b   Thomas, George ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HAMARTIN; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; PROTEIN S6K; RHEB PROTEIN; TUBERIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; EMBRYO; FEMALE; HUMAN; MOUSE; MUTATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0038433304     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00220-X     Document Type: Article

References (56)

1. Abraham R.T. Identification of TOR signaling complexes. more TORC for the cell growth engine Cell. 111:2002;9-12.
2. Bos J.L. Ras-like GTPases. Biochim. Biophys. Acta. 1333:1997;M19-M31.
3. Bourne H.R., Sanders D.A., McCormick F. The GTPase superfamily. a conserved switch for diverse cell functions Nature. 348:1990;125-132.
4. Brinkmann T., Daumke O., Herbrand U., Kuhlmann D., Stege P., Ahmadian M.R., Wittinghofer A. Rap-specific GTPase activating protein follows an alternative mechanism. J. Biol. Chem. 277:2002;12525-12531.
5. Brunn G.J., Hudson C.C., Sekulic A., Williams J.M., Hosoi H., Houghton P.J., Lawrence J.C. Jr., Abraham R.T. Phosphorylation of the translational repressor PHAS-I by the mammalain target of rapamycin. Science. 277:1997;99-101.
6. Chattopadhyay S., Roberts P.M., Pearce D.A. The yeast model for Batten disease. a role for Btn2p in the trafficking of the Golgi-associated vesicular targeting protein, Yif1p Biochem. Biophys. Res. Commun. 302:2003;534-538.
7. s6k. Proc. Natl. Acad. Sci. USA. 92:1995;11696-11700.
8. Cooper J.D. Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis. Curr. Opin. Neurol. 16:2003;121-128.
9. 389 are differentially regulated by rapamycin-insensitive kinase-kinases. Mol. Cell. Biol. 16:1996;6242-6251.
10. Dennis P.B., Fumagalli S., Thomas G. Target of rapamycin (TOR). balancing the opposing forces of protein synthesis and degradation Curr. Opin. Genet. Dev. 9:1999;49-54.
11. Dennis P.B., Jaeschke A., Saitoh M., Fowler B., Kozma S.C., Thomas G. Mammalian TOR. a homeostatic ATP sensor Science. 294:2001;1102-1105.
12. Gao X., Pan D. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev. 15:2001;1383-1392.
13. Gao X., Zhang Y., Arrazola P., Hino O., Kobayashi T., Yeung R.S., Ru B., Pan D. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat. Cell Biol. 4:2002;699-704.
14. Gingras A.C., Kennedy S.G., O'Leary M.A., Sonenberg N., Hay N. 4E-BP1, a repressor of mRNA translation, is phosphorylated and activated by the Akt (PKB) signaling pathway. Genes Dev. 12:1998;502-513.
15. Gingras A.C., Raught B., Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15:2001;807-826.
16. Goncharova E.A., Goncharov D.A., Eszterhas A., Hunter D.S., Glassberg M.K., Yeung R.S., Walker C.L., Noonan D., Kwiatkowski D.J., Chou M.M.et al. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J. Biol. Chem. 277:2002;30958-30967.
17. Gromov P.S., Madsen P., Tomerup N., Celis J.E. A novel approach for expression cloning of small GTPases. identification, tissue distribution and chromosome mapping of the human homolog of rheb FEBS Lett. 377:1995;221-226.
18. Hara K., Yonezawa K., Weng Q.P., Kozlowski M.T., Belham C., Avruch J. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 273:1998;14484-14494.
19. Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., Tokunaga C., Avruch J., Yonezawa K. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell. 110:2002;177-189.
20. Hidalgo M., Rowinsky E.K. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene. 19:2000;6680-6686.
21. Im E., von Lintig F.C., Chen J., Zhuang S., Qui W., Chowdhury S., Worley P.F., Boss G.R., Pilz R.B. Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells. Oncogene. 21:2002;6356-6365.
22. Inoki K., Li Y., Zhu T., Wu J., Guan K.L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4:2002;648-657.
23. International Molecular Genetic Study of Autism Consortium A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Hum. Mol. Genet. 7:1998;571-578.
24. Jaeschke A., Hartkamp J., Saitoh M., Roworth W., Nobukuni T., Hodges A., Sampson J., Thomas G., Lamb R. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. J. Cell Biol. 159:2002;217-224.
25. Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., Tempst P., Sabatini D.M. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 110:2002;163-175.
26. Liaw D., Marsh D.J., Li J., Dahia P.L., Wang S.I., Zheng Z., Bose S., Call K.M., Tsou H.C., Peacocke M.et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16:1997;64-67.
27. Loewith R., Jacinto E., Wullschleger S., Lorberg A., Crespo J.L., Bonenfant D., Oppliger W., Jenoe P., Hall M.N. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell. 10:2002;457-468.
28. Mach K.E., Furge K.A., Albright C.F. Loss of Rhb1, a Rheb-related GTPase in fission yeast, causes growth arrest with a terminal phenotype similar to that caused by nitrogen starvation. Genetics. 155:2000;611-622.
29. Maheshwar M.M., Cheadle J.P., Jones A.C., Myring J., Fryer A.E., Harris P.C., Sampson J.R. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis. Hum. Mol. Genet. 6:1997;1991-1996.
30. Manning B.D., Tee A.R., Logsdon M.N., Blenis J., Cantley L.C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell. 10:2002;151-162.
31. Marygold S.J., Leevers S.J. Growth signaling. TSC takes its place Curr. Biol. 12:2002;R785-R787.
32. Matsumoto S., Bandyopadhyay A., Kwiatkowski D.J., Maitra U., Matsumoto T. Role of the Tsc1-Tsc2 complex in signaling and transport across the cell membrane in the fission yeast Schizosaccharomyces pombe. Genetics. 161:2002;1053-1063.
33. McManus E.J., Alessi D.R. TSC1-TSC2. a complex tale of pkb-mediated S6k regulation Nat. Cell Biol. 4:2002;E214-E216.
34. ras. Nature. 371:1994;426-429.
35. Mizuki N., Kimura M., Ohno S., Miyata S., Sato M., Ando H., Ishihara M., Goto K., Watanabe S., Yamazaki M.et al. Isolation of cDNA and genomic clones of a human Ras-related GTP-binding protein gene and its chromosomal localization to the long arm of chromosome 7, 7q36. Genomics. 34:1996;114-118.
36. Montagne J., Radimerski T., Thomas G. Insulin signaling. lessons from the drosophila tuberous sclerosis complex, a tumor suppressor. Science's STKE:2001;;2001/105/pe36.pdf, http://stke.sciencemag.org/cgi/reprint/sigtrans.
37. Nojima H., Tokunaga C., Eguchi S., Oshiro N., Hidayat S., Yoshino K.I., Hara K., Tanaka N., Avruch J., Yonezawa K. The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. J. Biol. Chem. 278:2003;15461-15464.
38. Pearce D.A., Ferea T., Nosel S.A., Das B., Sherman F. Action of BTN1, the yeast orthologue of the gene mutated in Batten disease. Nat. Genet. 22:1999;55-58.
39. Potter C.J., Huang H., Xu T. Drosophila tsc1 functions with tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell. 105:2001;357-368.
40. Radimerski T., Montagne J., Hemmings-Mieszczak M., Thomas G. Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling. Genes Dev. 16:2002;2627-2632.
41. Radimerski T., Thomas G. Translational control and insulin signaling. Bradshaw R.A., Dennis E. Handbook of Cell Signaling. 2003;Academic Press, San Diego. in press.
42. Reuther G.W., Der C.J. The Ras branch of small GTPases. Ras family members don't fall far from the tree Curr. Opin. Cell Biol. 12:2000;157-165.
43. Schmelzle T., Hall M.N. TOR, a central controller of cell growth. Cell. 103:2000;193-200.
44. Sekulic A., Hudson C.C., Homme J.L., Yin P., Otterness D.M., Karnitz L.M., Abraham R.T. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 60:2000;3504-3513.
45. Sparagana S.P., Roach E.S. Tuberous sclerosis complex. Curr. Opin. Neurol. 13:2000;115-119.
46. Stocker H., Radimerski T., Schindelholz B., Belawat P., Wittwer F., Daram P., Breuer S., Thomas G., Hafen E. The small GTPase Rheb is an essential regulator of S6 kinase in the control of cell growth in Drosophila. Nat. Cell Biol. in press:2003.
47. Tapon N., Ito N., Dickson B.J., Treisman J.E., Hariharan I.K. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell. 105:2001;345-355.
48. Tee A.R., Fingar D.C., Manning B.D., Kwiatkowski D.J., Cantley L.C., Blenis J. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc. Natl. Acad. Sci. USA. 99:2002;13571-13576.
49. van Triest M., de Rooij J., Bos J.L. Measurement of GTP-bound Ras-like GTPases by activation-specific probes. Methods Enzymol. 333:2001;343-348.
50. Weng Q.-P., Andrabi K., Kozlowski M.T., Grove J.R., Avruch J. Multiple independent inputs are required for activation of the p70 S6 kinase. Mol. Cell. Biol. 15:1995;2333-2340.
51. Wienecke R., Konig A., DeClue J.E. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J. Biol. Chem. 270:1995;16409-16414.
52. Wolthuis R.M., de Ruiter N.D., Cool R.H., Bos J.L. Stimulation of gene induction and cell growth by the Ras effector Rlf. EMBO J. 16:1997;6748-6761.
53. Yamagata K., Sanders L.K., Kaufmann W.E., Yee W., Barnes C.A., Nathans D., Worley P.F. rheb, a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein. J. Biol. Chem. 269:1994;16333-16339.
54. Yee W.M., Worley P.F. Rheb interacts with Raf-1 kinase and may function to integrate growth factor- and protein kinase A-dependent signals. Mol. Cell. Biol. 17:1997;921-933.
55. Young J., Povey S. The genetic basis of tuberous sclerosis. Mol. Med. Today. 4:1998;313-319.
56. Zwartkruis F.J., Wolthuis R.M., Nabben N.M., Franke B., Bos J.L. Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling. EMBO J. 17:1998;5905-5912.